Edwards Larry Todd 4
4 · Arcutis Biotherapeutics, Inc. · Filed Oct 6, 2025
Insider Transaction Report
Form 4
Edwards Larry Todd
See Remarks
Transactions
- Sale
Common Stock
2025-10-02$19.99/sh−4,207$84,092→ 178,897 total - Sale
Common Stock
2025-10-02$20.78/sh−297$6,172→ 179,324 total
Footnotes (4)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on February 22, 2024.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $19.545 to $20.502, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $20.5593 to $20.995, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]Includes 724 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2025.